In combination therapy, the use of prodrug strategy along with Salmonella-expressing, prodrug-activating enzymes such as HSV TK, carboxypeptidase G2 (CPG2), and cytosine deaminase have more promising tumor retardation capabilities compared to the use of the therapeutic strain alone [15,56,150]. This evidence concerns the gene TKT and neoplasm.